EXSCIENTIA
Summary
Exscientia is a technology-driven drug design and development company, committed to creating more effective medicines for patients, faster.
Deals Overview
Total Deals5
Valued Deals4
Total Value£ 703 M
Avg. Deal Size£ 176 M
Senior Management
David Hallett
Interim CEO
Andrew Hopkins
CEO
Ben Taylor
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite